Stuart Scott Memorial Cancer Research Fund

The V Foundation established the Stuart Scott Memorial Cancer Research Fund in memory of celebrated ESPN sportscaster Stuart Scott after he passed away in 2015.

Donate to the Stuart Scott Fund

 

 

Donar al fonda conmemorativo de Stuart Scott

The Goal: Stop Cancer Disparities

Stuart was a dedicated friend to the V Foundation and a champion for cancer research. He enrolled in a clinical trial during his own cancer journey. Stuart was especially driven to improve outcomes for African Americans and other minorities disproportionately affected by cancer, and he became a passionate voice on their behalf.

The Stuart Scott Memorial Cancer Research Fund supports minorities through two types of grants.

Translational Grants fund research of cancer disparities experienced by patients of minority populations. The research topics include causes, aggressiveness, treatments or relapses of cancer.

The Fund also supports V Scholar scientists from minority ethnic groups underrepresented in science. This gives minority researchers important, early-career funding to establish their labs and begin their careers as cancer researchers.

Grants Awarded through the Stuart Scott Fund

“Fight Like Hell!” – Stuart Scott

Since inception of the Stuart Scott Fund, the V Foundation has made $10. 5 million in research grants from combined funds raised through the Sports Humanitarian Awards, Bristol-Myers Squibb and other generous donors. In total, the V Foundation has awarded 30 research grants at 23 cancer centers around the country.

In July 2014, Stuart received the Jimmy V Perseverance Award at the ESPY Awards. During his remarkable speech, he said, “When you die, it does not mean you lose to cancer. You beat cancer by how you live, why you live and in the manner in which you live.” Stuart passed away less than six months later at the age of 49. His extraordinary impact on cancer research continues.

 

Stuart Scott Fund Translational Grant Recipients

Victoria Bae-Jump, M.D., Ph.D. UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC Metabolic and Molecular Biomarkers of Metformin Response in Obesity-driven Endometrial Cancer Funded by the Stuart Scott Memorial Fund

Yanis Boumber, M.D., Ph.D. Fox Chase Cancer Center Philadelphia, PA Biomarkers of combined PD1 and VEGFR2 blockade in metastatic NSCLC Funded by the Stuart Scott Memorial Fund

Roisin Connolly, M.D. Sidney Kimmel Comprehensive Cancer Center/John Hopkins Medicine Philadelphia, PA Harnessing the Immune System to Treat Breast Cancer Funded by the Stuart Scott Memorial Fund

Sanford Markowitz, M.D., Ph.D. Case Comprehensive Cancer Center Cleveland, OH Interpreting the Mutational Signature of African American Colorectal Cancers Funded by the Stuart Scott Memorial Fund

Read More About Dr. Markowitz’s Research

Matthew Meyerson, M.D., Ph.D. Dana-Farber Cancer Institute Boston, MA The contribution of germline genomic variation to EGFR mutation frequency in non-small cell lung cancers in Latin American populations: implications for cancer risk prediction, screening and intervention. Funded by the Stuart Scott Memorial Fund

Read More About Dr. Meyerson’s Research

Adam Murphy, M.D. Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, IL A Prospective Validation of a Prostate Cancer Biomarker in African American Men Funded by the Stuart Scott Memorial Cancer Research Fund

Jong Park, Ph.D. Moffitt Cancer Center and Research Institute Tampa, FL Genomic predictors of aggressive and lethal prostate cancer in African-American men Funded by the Stuart Scott Memorial Fund

Read More About Dr. Park’s Research

Ralph Weissleder, M.D., Ph.D. Massachusetts General Hospital Cancer Center Boston, MA Enhanced holographic diagnostics and profiling of breast cancer using smartphones for point-of-care use Funded by the Stuart Scott Memorial Fund

Read More About Dr. Weissleder’s Research

Stuart Scott Fund V Scholar Grant Recipients

Claudio Alarcon, Ph.D. Yale Cancer Center New Haven, CT Epitranscriptomic Regulation of Cancer Metastasis Funded by the Stuart Scott Memorial Cancer Research Fund

Raymond Blind, Ph.D. Vanderbilt University School of Medicine Nashville, TN Nuclear lipids as hepatocellular carcinoma biomarkers Funded by the Stuart Scott Memorial Cancer Research Fund

Donita Brady, Ph.D. University of Pennsylvania School of Medicine Philadelphia, PA Targeting autophagy in KRAS-Driven pancreatic cancer via copper reduction Funded by the Stuart Scott Memorial Cancer Research Fund

Read More About Dr. Brady’s Research

Stephanie Correa, Ph.D. Jonsson Comprehensive Cancer Center Los Angeles, CA Hypothalamic targets for mitigating the side effects of adjuvant endocrine therapy Funded by the Stuart Scott Memorial Cancer Research Fund

Francine Garrett-Bakelman, M.D. University of Virginia Health System Charlottesville, VA Determining of an age-appropriate integrative risk classification in Acute Myeloid Leukemia Funded by the Stuart Scott Memorial Cancer Research Fund

Gianna Hammer, Ph.D. Duke Cancer Institute Durham, NC Microbiota induced upregulation of PDL√ on intestinal dendritic cells in intestinal tumorigenesis Funded by the Stuart Scott Memorial Cancer Research Fund

Read More About Dr. Hammer’s Research

Marcela Maus, M.D., Ph.D. Massachusetts General Hospital Cancer Center Boston, MA Design and pre-clinical evaluation of CAR T cells for myeloma Funded by the Stuart Scott Memorial Cancer Research Fund

Michelle Mendoza, Ph.D. Huntsman Cancer Institute, University of Utah Salt Lake City, UT Differential Regulation of Tumor Invasion by RSK Family Isoforms Funded by the Stuart Scott Memorial Cancer Research Fund

Akinyemi Ojesina, M.D., Ph.D. University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, AL Metatranscriptomic Biomarkers for Predicting Tumor Recurrence Funded by the Stuart Scott Memorial Fund

Miguel Rivera, M.D. Massachusetts General Hospital Cancer Center Charleston, MA Function of the protein kinase VRK1 in Ewing Sarcoma Funded by the Stuart Scott Memorial Fund

Read More About Dr. Rivera’s Research

Stuart Scott Fund Designated Grant Recipients

Jeffrey Clarke, M.D. Duke University Durham, NC Identification of Genetic Determinates for Disparities in African American Patients with Non-Small Cell Lung Cancer Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Read More About Dr. Clarke’s Research

Edward Kim, M.D. Levine Cancer Institute/Carolinas Health Care Charlotte, NC Dynamic functional assessment of the host (vs tumor) immune system in patients with non-small cell lung cancer utilizing a novel blood-based immunokinetic platform Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds, and the Richard Jones Fund for lung cancer.

Chad Pecot, M.D. The University of North Carolina at Chapel Hill Chapel Hill, NC Targeting the Immune Microenvironment to Treat Squamous Cancers Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Read More About Dr. Pecot’s Research

Qingy Wei, M.D., Ph.D. Duke Cancer Institute Durham, NC Characterization of functional variants of GWAS-identified CRL-related Gene DCAF4 for racial disparity in lung cancer Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds and the Richard Jones Fund for lung cancer.

Jared Weiss, M.D. UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC Targeting G2 Ganglioside in Small Cell Lung Cancer Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Stuart Scott Fund “Thrivership” Grant Recipients

Saro Armenian, DO, MPH City of Hope Comprehensive Cancer Center Duarte, CA Clonal hematopoiesis and its impact on outcomes after autologous hematopoietic cell transplantation Funded by the Stuart Scott Memorial Cancer Research Fund